|

INN805 Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • FindCure Biosciences (ZhongShan) Co., Ltd.1

Indications

  • Maligant Solid Tumor1
  • Lung Cancer - Non Small Cell Squamous1
  • Head Neck Cancer1
  • Sarcoma1
  • Thyroid Cancer1

Other1 trial

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.